Skip to content

Goodwill at other companies

TEC
Bio-TechneTECH
$977.8M+0.9%
Bruker logo
BrukerBRKR
$1.57B+2.6%
Illumina logo
IlluminaILMN
$1.28B+15.4%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$82.2M-4.2%
Revvity logo
RevvityRVTY
$6.61B+1.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$577.1M+39.2%

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s goodwill?
10x Genomics, Inc. (TXG) reported goodwill of $4.51M in Q1 2026.
How has 10x Genomics, Inc.'s goodwill changed year-over-year?
10x Genomics, Inc.'s goodwill decreased by 0.0% year-over-year, from $4.51M to $4.51M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.